Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-06-30 16:46:09 ET · period of report 2026-06-26 · accession 0002048588-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-30 16:46 | 2026-06-26+ | BBNX | Feider Stephen | CFO | M - OptEx | $5.10 | +9,878 | 170.8K | +6% | +$50.4K |
| DMT | 2026-06-30 16:46 | 2026-06-26+ | BBNX | Feider Stephen | CFO | S - Sale+OE | $17.04 | -10.0K | 165.9K | -6% | -$170.4K |
| DMT | 2026-06-30 16:46 | 2026-06-26+ | BBNX | Feider Stephen | CFO | M - OptEx | $0.00 | -9,878 | 39.8K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-26 | M | A | 4,982 | $5.10 | 171,035 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-26 | S | D | 5,104 | $17.05 | 165,931 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. (F2) The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2026-06-29 | M | A | 4,896 | $5.10 | 170,827 | D | — | — | |
| 4 | Common | Common Stock | 2026-06-29 | S | D | 4,896 | $17.03 | 165,931 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. (F3) The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2026-06-26 | M | D | 4,982 | $0.00 | 44,713 | D | $5.10 · — to 2033-09-13 | 4,982 Common Stock | (F4) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2026-06-29 | M | D | 4,896 | $0.00 | 39,817 | D | $5.10 · — to 2033-09-13 | 4,896 Common Stock | (F4) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |